Feed CRSF
Summary
20 / 100 · Bulios Score
Valuation 0Growth 58Profitability 20Quality 0Debt 40Stability 5
What speaks for it
None of the indicators we track stands out on the positive side.
What to watch
- The company made a loss over the last 12 months.
- It passes only 3 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
20212022202320242025
Diluted EPS (USD)
20212022202320242025
Revenue grew by 8.0% a year over the last 3 years.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $19.2M.
Profitability in detailIs it financially healthy?
Debt is a burdenCash and short-term investments $100.5K
Debt $751.9K
Free cash flow over 12 months -$2.75M
Over the last 12 months it spent more cash than it brought in. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Collectibles 100%
By region
The company reports no revenue by region.
Collectibles brings in 100% of revenue.
Segments in detail